News | January 25, 2024
Aarti Drugs posts Q3 FY24 consolidated PAT at Rs. 36.71 Cr
Aarti Drugs has reported total income of Rs. 607.61 crores during the period ended December 31, 2023
Aarti Drugs has reported total income of Rs. 607.61 crores during the period ended December 31, 2023
The company also plans to boost its India presence by adding 1,500 beds in the next 2-3 years
India’s First Integrated Ayush Wellness Centre to come up in Guwahati, foundation stone laid
The three-day forum will feature global leaders, scientists, regulatory body representatives, industry associations, and academia among many others
Submission based on positive results from global phase 3 study demonstrating overall survival benefit of TIVDAK over chemotherapy
The company has secured two orders for male condoms from CMSS worth Rs. 9.65 crores and Rs. 6.58 crores respectively
Dedicates upgraded National Centre for Disease Control, Delhi and a Temporary Regional Branch of NCDC to the nation
The establishment of the facility demonstrates the company's commitment to delivering differentiated solutions to gynecology and pediatrics challenges
The commissioning of the facility represents the culmination of a £45m investment to address rapidly growing demand for ADC manufacturing, supported by a £2.4m Scottish Enterprise grant
Development services for gene and cell therapies is planned to begin first in 2025
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
